Back
Biogen, Inc. Vs. Ascendis Pharma A/S Industry Stock Comparison
Sell
50
BIIB
Biogen, Inc.
Last Price:
$176.48
Seasonality Move:
8.72%
Sell
48
ASND
Ascendis Pharma A/S
Last Price:
$212.84
Seasonality Move:
19.56%
Sell
50
Biogen, Inc. (BIIB)
is a Sell
Is Biogen, Inc. a Buy, Sell or Hold?
-
The current Biogen, Inc. [BIIB] share price is $174.82. The Score for BIIB is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
-
BIIB is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Ascendis Pharma A/S (ASND)
is a Sell
Is Ascendis Pharma A/S a Buy, Sell or Hold?
-
The current Ascendis Pharma A/S [ASND] share price is $209.23. The Score for ASND is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
-
ASND is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
BIIB Stock Price Chart
What is Biogen, Inc.'s stock price today?
-
The Biogen, Inc. share price today is $174.82Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BIIB is experiencing slight buying pressure.
ASND Stock Price Chart
What is Ascendis Pharma A/S's stock price today?
-
The Ascendis Pharma A/S share price today is $209.23Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing slight selling pressure.
BIIB Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.05 | Buy |
| Relative Strength Index (14 RSI): | 54.84 | Buy |
| Chaikin Money Flow: | 502428 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (171.45 - 180.47) | Sell |
| Bollinger Bands (100): | (136.37 - 168.21) | Buy |
ASND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.2 | Buy |
| Relative Strength Index (14 RSI): | 52.22 | Buy |
| Chaikin Money Flow: | -9154 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (202.29 - 213.47) | Buy |
| Bollinger Bands (100): | (194.03 - 209.07) | Buy |
BIIB Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 173.46 | Buy |
| 20-day SMA: | 177.1 | Sell |
| 50-day SMA: | 164.12 | Buy |
| 200-day SMA: | 140.31 | Buy |
| 8-day EMA: | 174.19 | Buy |
| 20-day EMA: | 173.65 | Buy |
| 50-day EMA: | 166.11 | Buy |
| 200-day EMA: | 152.66 | Buy |
ASND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 208.38 | Buy |
| 20-day SMA: | 206.94 | Buy |
| 50-day SMA: | 205.8 | Buy |
| 200-day SMA: | 182.92 | Buy |
| 8-day EMA: | 206.78 | Buy |
| 20-day EMA: | 206.81 | Buy |
| 50-day EMA: | 205 | Buy |
| 200-day EMA: | 185.01 | Buy |
Biogen, Inc. Earnings Growth & BIIB Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.19 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.32 per share, and an increase next year of $0.17 per share.
Ascendis Pharma A/S Earnings Growth & ASND Earnings Dates
-
Analysts estimate an earnings increase this quarter of $1.33 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.02 per share, and an increase next year of $7.69 per share.
Biogen, Inc. Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ascendis Pharma A/S Technical Analysis
| Dec 10 | Dec 11 | Dec 12 | Dec 15 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 22 | Dec 23 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec | ||||||||||
| 10 | 11 | 12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||